 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 2/1 | 返回列表 |
| 查看: 4841 | 回復(fù): 451 | |||||||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||||||
jiangsishui
|
[交流]
【歡迎工程學(xué)科投稿】?SCI，影響因子2.6?第2屆?2019年美洲醫(yī)學(xué)影像與臨床研究國(guó)際&
|
||||||
amicr 2019 網(wǎng)站：https://www.amicr-conf.com/index.htm we are pleased to announce that 2019 2nd americas conference on medical imaging and clinical research (amicr 2019) will be held on august 8-10, 2019, toronto, canada. toronto is the capital city of the province of ontario and the largest city in canada by population, with 2,731,571 residents in 2016. current to 2016, the toronto census metropolitan area (cma), of which the majority is within the greater toronto area (gta), held a population of 5,928,040, making it canada most populous cma. toronto is the anchor of an urban agglomeration, known as the golden horseshoe in southern ontario, located on the northwestern shore of lake ontario. a global city, toronto is a centre of business, finance, arts, and culture, and is recognized as one of the most multicultural and cosmopolitan cities in the world. 2018 americas conference on medical imaging and clinical research (amicr 2018) has been successfully held on december 23-25, 2018,panama city, panama.amicr 2018 paper abstract has been published by a sci journal basic & clinical pharmacology & toxicology (issn: 1742-7835, e-issn:1742-7843) volume 124, issue s2, which has been indexed by web of science science citation index (sci) and web of science science citation index expanded (scie) within 1 month after conference date.the impact factor of this sci journal is 2.659. amicr 2019 will be the most comprehensive conference focused on the various aspects of medical imaging and clinical research,public health,modern medicine,health science,and information technology. our conference provides a chance for academic and industry professionals to discuss recent progress in the area of medical imaging and clinical research,public health,modern medicine,health science,and information technology. the goal of this conference is to bring together the researchers from academia and industry as well as practitioners to share ideas, problems and solutions relating to the multifaceted aspects of medical imaging and clinical research,public health,modern medicine,health science,and information technology. amicr 2019 is co-sponsored by american applied sciences research institute,usa,information engineering research institute,usa and singapore management and sports science institute,singapore. amicr 2019 is also technically co-sponsored by technical university of kosice, slovakia,democritus university of thrace, greece and chulalongkorn university, thailand. all amicr 2019 paper abstract will be published by a sci journal basic & clinical pharmacology & toxicology (issn: 1742-7835, e-issn:1742-7843) , which will be indexed by web of science science citation index (sci) and web of science science citation index expanded (scie) . the impact factor of this sci journal is 2.659. 2018 americas conference on medical imaging and clinical research (amicr 2018) has been successfully held on december 23-25, 2018,panama city, panama. amicr 2018 paper abstract has been published by a sci journal basic & clinical pharmacology & toxicology (issn: 1742-7835, e-issn:1742-7843) volume 124, issue s2, which has been indexed by web of science science citation index (sci) and web of science science citation index expanded (scie) within 1 month after conference date.the impact factor of this sci journal is 2.659. important dates third round paper submission due: june 30 , 2019 notification of acceptance :1-3 working days reviewing after submission authors registration: see the notification letter conference date : august 8-10, 2019 abstract edited by publisher date: july, 2019-august, 2019 journal publishing conference date : august, 2019 paper submission-submission guide step 1: submission ( by email) the submission email: amicr2019@smssi.net more information see: https://www.amicr-conf.com/sub.htm amicr 2019 conference location double tree by hilton toronto airport 925 dixon road, toronto, ontario, m9w 1j8  https://doubletree3.hilton.com/e ... -ytoapdt/index.html [ last edited by jiangsishui on 2019-6-18 at 10:27 ] [ last edited by jiangsishui on 2019-6-18 at 10:29 ] [ last edited by jiangsishui on 2019-6-19 at 11:11 ] [ Last edited by jiangsishui on 2019-6-19 at 17:05 ] |
回復(fù)此樓» 本帖已獲得的紅花（最新10朵）
icebaby20» 猜你喜歡
一志愿北京化工大學(xué)材料與化工296分求調(diào)劑
已經(jīng)有17人回復(fù)
-
0703化學(xué)一志愿211 總分320求調(diào)劑
已經(jīng)有3人回復(fù)
-
0703求調(diào)劑
已經(jīng)有6人回復(fù)
-
（081700）化學(xué)工程與技術(shù)-298分求調(diào)劑
已經(jīng)有6人回復(fù)
-
一志愿天津大學(xué)材料與化工275求調(diào)劑
已經(jīng)有22人回復(fù)
-
0857 資源與環(huán)境 285分
已經(jīng)有6人回復(fù)
-
材料工程,326分，求調(diào)劑
已經(jīng)有5人回復(fù)
-
301求調(diào)劑
已經(jīng)有5人回復(fù)
-
334求調(diào)劑
已經(jīng)有3人回復(fù)
-
材料與化工085600調(diào)劑求老師收留
已經(jīng)有5人回復(fù)
» 搶金幣啦！回帖就可以得到:
-
男征女，上海找一個(gè)真誠(chéng)結(jié)婚的女朋友
+1/173
-
2026年西華大學(xué)材料學(xué)院-材料近凈成形與表面技術(shù)研究團(tuán)隊(duì)-招收研究生
+1/85
-
招聘有機(jī)合成人員，新成立部門，上升空間大
+1/80
-
西安建筑科技大學(xué)，樊重慶課題組招收調(diào)劑研究生1名。
+2/58
-
華中科技大學(xué)物理學(xué)院于濤教授課題組 2026年擬招收優(yōu)秀考研生1名
+2/42
-
廣東工業(yè)大學(xué)管理科學(xué)與工程專業(yè)博士招生
+1/37
-
寧夏大學(xué)青年長(zhǎng)江學(xué)者團(tuán)隊(duì)招收2026級(jí)有機(jī)化學(xué)方向?qū)徍酥撇┦可?/a>
+2/36
-
廈門大學(xué)航空航天學(xué)院智能制造課題組招2026年申請(qǐng)審核制博士生1名
+1/26
-
博士后招聘（高薪40萬(wàn)+）
+1/19
-
26年博士招生
+1/17
-
江西理工大學(xué)稀土學(xué)院/國(guó)家稀土功能材料創(chuàng)新中心招收博士研究生和調(diào)劑碩士研究生
+1/9
-
食品科學(xué)與工程083200-297分
+1/8
-
連發(fā)兩篇 Nature！大樣本單細(xì)胞測(cè)序解析認(rèn)知、衰老與靈長(zhǎng)類進(jìn)化
+1/5
-
浙江大學(xué)楊林課題組招聘藥物化學(xué)與有機(jī)合成方向博士后
+1/4
-
284 求調(diào)劑
+1/4
-
總分291英一、數(shù)二-中核論文（導(dǎo)師一作、本人二作）-一志愿211學(xué)碩-自我介紹詳細(xì)
+1/3
-
用AI來(lái)進(jìn)行基金或評(píng)獎(jiǎng)項(xiàng)目的函評(píng)，非常靠譜
+1/3
-
礦業(yè)工程招收碩士研究生
+1/3
-
雙一流天津工業(yè)大學(xué)電信學(xué)院李鴻強(qiáng)教授招收2026年申請(qǐng)審核制博士3名
+1/2
-
315求調(diào)劑
+1/1
72樓2019-06-18 08:31:11
簡(jiǎn)單回復(fù)
tzynew2樓
2019-06-18 06:05
回復(fù)
jiangsishui(金幣+2): 謝謝參與
8 發(fā)自小木蟲Android客戶端
nono20093樓
2019-06-18 06:09
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20094樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20095樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20096樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20097樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20098樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono20099樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono200910樓
2019-06-18 06:10
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono200911樓
2019-06-18 06:11
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
nono200912樓
2019-06-18 06:13
回復(fù)
jiangsishui(金幣+2): 謝謝參與
。 發(fā)自小木蟲Android客戶端
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 求調(diào)劑 +5 | yfihxh 2026-03-09 | 5/250 |
|
|---|---|---|---|---|
|
|
[考研] 337一志愿華南理工0805材料求調(diào)劑 +3 | mysdl 2026-03-11 | 5/250 |
|
|
|
[考研] 化工0817調(diào)劑 +8 | 燦若星晨 2026-03-10 | 8/400 |
|
|
|
[考研] 調(diào)劑 +5 | 呵唔哦豁 2026-03-10 | 5/250 |
|
|
|
[考博] 26申博求助 +3 | 跳躍餅干 2026-03-10 | 4/200 |
|
|
[考研] 315食品工程求調(diào)劑 +4 | Oreov0 2026-03-06 | 7/350 |
|
|
|
[考研] 收調(diào)劑 +7 | 調(diào)劑的考研學(xué)生 2026-03-10 | 7/350 |
|
|
|
[考研] 材料與化工求調(diào)劑 +11 | 與冬清寧 2026-03-07 | 14/700 |
|
|
|
[考博] 找博導(dǎo) +4 | 小呆呆熊 2026-03-07 | 4/200 |
|
|
|
[考研] 085600材料與化工 326 求調(diào)劑 +4 | 熱愛生活ing 2026-03-09 | 4/200 |
|
|
|
[基金申請(qǐng)] 面上項(xiàng)目還需要AI說明嗎？ +3 | liyundong 2026-03-08 | 3/150 |
|
|
|
[考研] 數(shù)二英二309分請(qǐng)求調(diào)劑 +3 | dtdxzxx 2026-03-09 | 4/200 |
|
|
|
[考研] 考研調(diào)劑，一志愿山東大學(xué)材料與化工，328分，政治51 +5 | 關(guān)你西紅柿929 2026-03-08 | 6/300 |
|
|
|
[考研] 求0856調(diào)劑 +5 | 小力氣珂珂 2026-03-08 | 5/250 |
|
|
|
[考研] 一志愿211 材料與化工 280求調(diào)劑 +3 | Sanity蔣 2026-03-08 | 3/150 |
|
|
|
[考研] 一志愿武理314求調(diào)劑 +4 | （￣～￣;） 2026-03-08 | 5/250 |
|
|
|
[考研] 347求調(diào)劑 +4 | 浮云滿足 2026-03-07 | 4/200 |
|
|
|
[考研]
 085600材料與化工 292分 求調(diào)劑
+6
|
程晴之 2026-03-06 | 6/300 |
|
|
|
[考研] 08工科求調(diào)劑 +3 | 隆LLL 2026-03-06 | 4/200 |
|
|
|
[考研] 334求調(diào)劑 +6 | Trying] 2026-03-05 | 8/400 |
|